Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lees

Showing results (741-750 of 1,055) with videos related to

Pageof 106
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|April 21, 1999
The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseasesH R Morris, J C Janssen, O Bandmann, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|April 27, 2004
Parental lead exposure and total anomalous pulmonary venous returnLeila W Jackson, Adolfo Correa-Villaseñor, Peter S J Lees, et al.
Clinical Neuropharmacology|October 1, 1989
A double-blind, controlled study of high-dose L-deprenyl in the treatment of Parkinson's diseaseJ P Frankel, P A Kempster, C M Stibe, et al.
Journal of Neurochemistry|September 1, 1997
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigraZ I Alam, A Jenner, S E Daniel, et al.
Annals of Neurology|September 1, 1994
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal gangliaJ Sian, D T Dexter, A J Lees, et al.
Neuroscience Letters|October 12, 2001
Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophyH R Morris, A Schrag, U Nath, et al.
Neuroscience|May 1, 1995
Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's diseaseA P Nisbet, O J Foster, A Kingsbury, et al.
Lancet (London, England)|October 15, 1977
Deprenyl in Parkinson's diseaseA J Lees, K M Shaw, L J Kohout, et al.
Annals of Neurology|July 1, 1991
Dopa-responsive dystonia: [18F]dopa positron emission tomographyG V Sawle, K L Leenders, D J Brooks, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findingsAndrew H Evans, Durval C Costa, Sveto Gacinovic, et al.
Pageof 106

Showing results (741-750 of 1,055) with videos related to

Sort By:
Pageof 106
Journal of Neurology, Neurosurgery, and Psychiatry|April 21, 1999
The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseasesH R Morris, J C Janssen, O Bandmann, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|April 27, 2004
Parental lead exposure and total anomalous pulmonary venous returnLeila W Jackson, Adolfo Correa-Villaseñor, Peter S J Lees, et al.
Clinical Neuropharmacology|October 1, 1989
A double-blind, controlled study of high-dose L-deprenyl in the treatment of Parkinson's diseaseJ P Frankel, P A Kempster, C M Stibe, et al.
Journal of Neurochemistry|September 1, 1997
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigraZ I Alam, A Jenner, S E Daniel, et al.
Annals of Neurology|September 1, 1994
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal gangliaJ Sian, D T Dexter, A J Lees, et al.
Neuroscience Letters|October 12, 2001
Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophyH R Morris, A Schrag, U Nath, et al.
Neuroscience|May 1, 1995
Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's diseaseA P Nisbet, O J Foster, A Kingsbury, et al.
Lancet (London, England)|October 15, 1977
Deprenyl in Parkinson's diseaseA J Lees, K M Shaw, L J Kohout, et al.
Annals of Neurology|July 1, 1991
Dopa-responsive dystonia: [18F]dopa positron emission tomographyG V Sawle, K L Leenders, D J Brooks, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findingsAndrew H Evans, Durval C Costa, Sveto Gacinovic, et al.
Pageof 106